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Dr Bavaria. Cherrie, I will ask you a question first. You know
that, especially in atherosclerotic aneurysms, the orifices of the in-
nominate and the carotid are pretty loaded with plaque a lot of the
time. Both the hybrid and the standard procedures avoid confront-
ing that by inserting the branches distally. Chuter’s original data
showed a 25% stroke rate, or something equally horrible; that is
why it was stopped. How are you going to deal with the special
considerations regarding manipulations of the orifices of the aortic
branches and stroke risk?
Dr Abraham. I agree; I am as concerned as you are. I think one
of the problems with the Chuter device—and any procedure in
which you are going retrograde with a large-profile delivery sys-
tem—is that you are going to be rubbing against these atheroscle-
rotic lesions. The advantage of the arch graft is the manipulation at
that level is fairly minimal because you are only using catheters
andwires, and then a fairly low profile stent-graft such as a Fluency
or a Gore Viabahn.
I think, as I said, that severe atherosclerosis is a contraindication.
If you see significant occlusive disease or calcification in the prox-
imal trunks of these vessels, I don’t think you should do this kind of
graft. If the branch vessels are fairly clean or mildly atheromatous,
however, I think you can get away with the branch technique. I am
a little bit more worried about putting in fenestrated grafts, espe-
cially with the preloaded wire system, because they’ll just rub
across all that debris. But as Dr Yokoi showed, I am pretty im-
pressed with the fact that maybe we don’t need to use a preloaded
wire or catheter to maintain alignment.
Dr D. Craig Miller (Stanford, Calif). All of us know that ma-
ternity is never in question, but paternity is suspect, and I shudder
a little bit having had something to do 20 years agowith the advent
of thoracic aortic stent-grafting. Whether I am the mother or the
father, who knows, but I am responsible in some sense for whatres: Authors have nothing to disclose with regard to commercial support.
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Dr Abraham. You refer that patient to a surgeon who can do it right
with reasonable results. I didn’t see anything inoperable about that
patient. And for thosewho are inoperable, there are more and more
thoracic endovascular aortic repairs (TEVARs) being done, but
fewer and fewer patients are living 5 years later because we are do-
ing TEVARs in patients who are dying of other things. It is equiv-
alent to cohort C for the percutaneous aortic valve, and it is futile
therapy. So convince me that a patient is inoperable, and then
maybe TEVAR is the thing to do. It is exciting, it is new, but the
results I just don’t think you can justify.
Now, let me ask my question of Joe and Martin. You both have
the most wonderful platform to do it right if you can justify it, and I
am not going to get into the debate that you can’t do it the tradi-
tional way or Nick’s way. If they are doing something in the as-
cending aorta and you are going to do a hybrid, I heard Martin
say that you might come back another day and do a retrograde
stent-graft. But why not do it antegrade at the same time, when
you have so much better control of everything? Why would either
of you do a 2-stage and come up from below with its risks, which
you certainly don’t have when you are in the ascending aorta
anyway?
Dr Bavaria. I totally agree with antegrade versus retrograde
stenting. After operating in the ascending aorta, we would do al-
most all of our cases with an antegrade stent. Occasionally, we
will get into some issues that make it a little bit difficult techni-
cally; usually, if we do a retrograde stent, it is unplanned. We
just get to the technical portion of the operation and we see that
we can’t put an antegrade stent in very easily, so we stop, and
come back 2 or 3 or 4 days later and put in a retrograde stent. To
be honest, there are some political issues with this operation in
the hospital, and occasionally it is a primary vascular surgery pa-
tient and the surgeons like to put the stents in retrograde. But that is
not really a medical reason.
Dr Czerny. Actually for us there are 2 reasons not to go for an
antegrade delivery. The first is that you lose landing zone. If you
insert the stent-graft through the ascending aorta with a side graft,
you always lose at least 2 cm of what you have just gained by
transposition.
And the second reason is that most prostheses are built and
designed for retrograde delivery. There is actually just 1 pros-
thesis—the Gore prosthesis—for which I think from thegery c March 2013
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or retrograde fashion, because it opens up from the middle,
and there are not bare springs on one side and not on the other.
These are the 2 reasons for us to remain with the retrograde
approach.
Dr Bavaria. I repeat, we usually do the antegrade approach.
DrMiller. I don’t buy those excuses. What is wrong with using
the Gore antegrade?
Joe Coselli, you have been a proponent of going antegrade if
you are there anyway. Do you see a reason to come back another
day and buy those risks?
Dr Czerny. Regarding a synchronous or a metachronous ap-
proach, I think it is a matter of setting. Previously, when we did
not have a hybrid operating room, we would have to cross half
the hospital to come to the radiology suite to insert a stent-graft,
because we had no ability to do it in the operating room. In our cur-
rent setting, we do have this ability, and this is why we routinely
perform it synchronously now.
Dr Coselli. I really hate to see political issues get in the way of
the care of a patient. I know I am part of a dying breed, but the way
we have solved it in my unit is that I am the vascular surgeon as
well as the cardiac surgeon. So the decision is made at the time,
and everything is taken care of under a single anesthetic.
Dr Miller. Dr Griepp, how is your blood pressure after hearing
some of these presentations?
Dr Griepp. A lot of these things have great potential for the fu-
ture. The present is not quite so wonderful, but we do have hopes
that they will get better as time goes on.
Dr Abraham. Joe, can I just say one thing just to address Dr
Miller’s comments? He made a remark about my finding a cardiac
surgeon to do these cases. I just want to make sure that everybody
is clear: I don’t go out trying to find cardiac surgeons to work on
these patients; it is the cardiac surgeons who are contacting me.
Mark Peterson in Toronto, Marc Pelletier from New Brunswick,
MikeMoon inWinnipeg: I can tell you that there are not many car-
diac surgeons better than those surgeons in those cities. So it might
be difficult for me to find a cardiac surgeon, but perhaps I could
send them to Stanford.
Dr Miller. Or you can send them to Baja Oklahoma. I am sure
there is someone in Houston who would help out.
Dr Bavaria. I would back him up. Most of the cases that were
presented in the Cook trial were actually referred by cardiac
surgery.
Dr Jonathan Nwiloh (Atlanta, Ga). My question is for Dr
Griepp. You had mentioned significant differences between hypo-
thermic cardiac arrest (HCA) and non-HCA groups in terms of
postoperative neurocognitive function. I wanted to know whether
that difference normalizes with time, or whether it continues to
persist into the long term?
A second question concerns your mentioning that the safe time
for circulatory arrest is about 25 to 30 minutes, and I was wonder-
ing whether retrograde cerebral perfusion (RCP) or selective ante-
grade cerebral perfusion (ACP) extends that safety margin, and if
so for how long?
Dr Griepp. Did your first question refer to cognitive testing?
Dr Nwiloh. Yes: whether the postoperative differences in cog-
nitive testing persist with time or whether the difference between
the 2 groups in your series normalizes.The Journal of Thoracic and CardDr Griepp. Those figures that I showed you were from late
tests. Some of those patients were tested within a week or so,
but the quoted results were from patients 2 weeks postopera-
tively to as long as 6 months after surgery: we didn’t have a fur-
ther test at 1 year. We did see some change in those patients in
whom we did early tests and late tests, but I think the quoted
results probably are reasonably representative in terms of
persistence.
One of the problems is that the further out you go, the more dif-
ficult it is to know what it means, because there are other changes
that are going on. I suspect that if you took these same patients and
tested them 2 years later, theywould probably all doworse because
they are older and many of them have atherosclerosis and so forth.
So there is no perfect answer in terms of when to test, but we were
convinced on the basis of this and on some subsequent studies that
there are real decrements in performance. I would remind you that
in routine cardiac surgical patients, and in patients with short
periods of circulatory arrest, we didn’t see any deterioration
whatsoever.
Dr Bavaria. The second question was about RCP and HCA and
whether RCP can increase that safe time as an adjunct to ACP.
DrGriepp.Well, I can give youmy prejudices that are based on
some laboratory data and some very limited clinical experience.
There is no evidence that RCP provides nutritive support to the
capillaries of the brain in the experimental animal, and I think
that is probably also true in human beings. I think that RCP can
be helpful during periods of hypothermic circulatory arrest as an
adjunct to cooling, but I think that we have shown in the experi-
mental animal—and I suspect it is also true in human beings—
that you can keep the brain just as cold by packing the head in
ice as with RCP. I’m sorry that Dr Safi isn’t here. He is among
the last holdouts of RCP to defend that practice. But I don’t believe
RCP does much good.
In terms of ACP, I think that is an entirely different situation. I
think ACP is not HCA, and I suspect that you can go on for quite
long intervals with ACP. Indeed, I think in most of the clinical se-
ries that I have seen, and from people that I have talked to who use
a lot of ACP, the major issue having to do with duration has to do
with distal body HCA. And if you are going to put a catheter in the
descending aorta while you do ACP, you are basically doing
cardiopulmonary bypass. I think if you want to use long periods
of selective cerebral perfusion without distal perfusion, you have
to be pretty cold. But on the basis of our experience with cold
selective cerebral perfusion—and Dr Bachet can speak to this,
although he never went as long as we did—you can probably go
for an hour and a half, maybe as long as 2 hours, without any
difficulty.
Dr Santi Trimarchi (San Donato, Italy). I have a question for
Dr Yokoi. First, thank you very much for your presentation, which
looks extraordinary. You report on about 400 patients. It looks very
curious if we compare your results with the results from Dr Abra-
ham, who used a kind of conventional branched graft. You reported
about the fenestrated graft, but if I understood correctly, you don’t
have any side branch. I would like to know something more about
what type of stent you have. Is it nitinol? Do you use balloon
dilatation in these patients? What type of oversizing do you
use? And what are your results in terms of endoleak and the
long-term results? What is your longest follow-up?iovascular Surgery c Volume 145, Number 3S S119
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a branched graft, because many surgeons have a special technique
in Japan. We must limit embolic stroke and the complications
within open surgical repair. So my investigation is very simplified,
and safety is the most important issue. Stent-grafting is one of the
therapies for thoracic aortic disease. Safety is the most important
aim, and the second is the right indication. These patients are
not fit for surgical therapy. During deployment, we use blood pres-
sure to expand the stent-graft to the proximal landing zone, and
70% of patients don’t need touch-up balloon dilatation.
Dr Bavaria. I think this is a multicenter national trial for Japan,
I am sure it will be published pretty soon, and we will have to wait
for that information for more detail.
Dr George Tolis, Jr (Boston, Mass). I have a question for Dr
Spielvogel. In terms of the trifurcated graft technique, which
you and Dr Griepp taught me how to do, I have noticed that it
seems to be easier to just do the subclavian artery under circulatory
arrest and then clamp the distal stumps of the left common
carotid and the brachiocephalic artery and do these under blind
selective perfusion through the axillary cannula at about 10 mL/
kg/min. That decreases the circulatory arrest time a fair amount.
You end up having about 8 or 10 minutes of circulatory arrest,
the time that it takes to dissect out the arch and do the subclavian
anastomosis, which is the hardest one to do. And then you convert
the rest of the 20 minutes or whatever that would normally be cir-
culatory arrest into blind unilateral selective perfusion. Do you
think there is any problem with doing it this way? Do you think
there are any drawbacks?
Dr Spielvogel. Actually, George, I think that your approach is
right on the money, absolutely. I always think that the left subcla-
vian is the most difficult to access when you are doing arch re-
placement; sometimes it’s really displaced away from you. So
actually that’s exactly what I do; I always do the left subclavian
first. And as time has gone on, we have gotten to the approach in
which you begin perfusion unilaterally and just occlude the bra-
chiocephalic vessels and sew the rest of the graft on. So, yes,
you can do it in less than 10 minutes. I almost always do the left
subclavian under circulatory arrest; it just seems easier.
Dr Tolis. You can inspect the vessels and see whether they are
diseased. If they are diseased, then obviously you wouldn’t clamp
them, but usually the distal stumps are fairly disease free in the
arches, at least in my experience.
Dr Spielvogel. Absolutely. I agree.
DrCoselli.Wedo something quite similar.We use a trifurcation
graft, and we will go to the left subclavian while we are cooling,
and then you can perfuse through the trifurcation graft into the
left subclavian, so that you are hitting your vertebral while you
are doing the left carotid, and you are meanwhile perfusing
through the axillary artery into the right carotid. And then under
circulatory arrest you move the innominate artery, and while you
are doing the innominate, you are perfusing all the head vessels.
And so it adds body circulatory arrest time, but your cerebral cir-
culatory arrest is over at that point. It really brings cerebral circu-
latory arrest time down to just a few minutes while you are doing
the left carotid.
Dr Tolis.And under deep hypothermia or relative hypothermia?
Dr Coselli. We use 24C. We fall between some of those that
are interested in perfusion at the higher levels of temperature,S120 The Journal of Thoracic and Cardiovascular Surbut we have a great deal of respect for some of the data that has
come out of the group at Mount Sinai, so we have arbitrarily
gone to about 24C.
Dr Tolis. So I would assume that under deep hypothermia you
wouldn’t be nervous about the circulatory arrest time involving the
vertebral?
Dr Coselli. Certainly less so. I also think, however, that there is
a group of patients in whom, during the cooling period, it is going
to be hard to get to that left subclavian. So I think you need to look
at the anatomic considerations, and there may be some people who
should have carotid–subclavian bypass to eliminate that factor.
Again, however, that is a patient selection issue.
Let me add just one more thing to that. I haven’t heard it men-
tioned yet, but we have run into some patients with large vertebral
arteries coming off the transverse aortic arch and have elected to
maintain patency of those. On occasion, we have reattached
them to that Dacron polyester fabric graft that goes off to the
left subclavian, but more often than not we just reattach them to
the left carotid.
Dr Eric Roselli (Cleveland, Ohio). First, I would like to make
a comment with regard to the discussion that went on earlier about
antegrade delivery of stent-grafts. In our experience, we have had
a couple of patients who had some spinal cord ischemia related to
extensive coveragewith the antegrade delivery of stent-grafts. And
so we have learned, despite having cerebrospinal fluid drainage,
that if we have to cover an extensive amount of thoracic aorta, it
is probably best, as Dr Griepp has taught us, to break up that insult
over time and do that second operation retrograde maybe 5 days or
a week later.
I also have a question for Dr Yokoi about the fenestrating de-
vice. Those are fascinating images, but what sort of rescue strate-
gies do you have in place in the event that you can’t get access or
can’t get the fenestrations lined up with those vessels? It didn’t
look like there were very many wires in those aortas on those
images you showed.
Dr Yokoi. We have 3 chimney stents in the operation, and the
alignment—the rotation of the device—is no problem because
we have a lot of experience. The problem is if it is too proximal
or too distal. If too proximal, then after deployment we can put
a stent from the left common carotid into the sheath with bare stent
chimney stenting. We have no complications, or almost no compli-
cations, because we have a lot of cases.
Dr Roselli. So in the 3 patients that you had to salvage, you
were able to access the fenestrations with a stent?
D. Yokoi. Yes.
Dr Roselli.Are the fenestrations on the device custom designed
for the patients?
Dr Yokoi. They are custom designed, but we have already set-
tings prepared, so that the stent can be fabricated very quickly just
by selecting from the various types of fenestrations. Sowe can start
a clinical trial.
Dr Roselli. So there are fewer variations in the arch than in the
thoracoabdominal aortic branches?
Dr Yokoi. Yes.
Dr Jehangir Appoo (Calgary, Alberta, Canada). I have 2 ques-
tions, 1 for Dr Yokoi and 1 for Dr Hagl. Dr Yokoi, I am very im-
pressed that you have this series of 350 totally endovascular
arches. It is very impressive. I noticed I think that 3 of themgery c March 2013
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aortic dissections and whether you are moving toward using this
therapy in the acute situation.
I also wanted to ask Dr Hagl what their standard approach is for
an acute type A dissection and their indications for an elephant
trunk in acute type A dissection.
Dr Yokoi. Three patients had previously had type A chronic
aortic dissection. They just had little endoleaks after the procedure,
sowewere required to perform touch-up ballooning. One patient is
currently in conservative follow-up, and 2 patients were taken to
open surgery.
Dr Appoo. Would you consider using this for an acute type A
dissection?
Dr Yokoi. I think that is the next program for me.
Dr Hagl. I think the most important thing in a type A aortic
dissection is that the patient survives. That is the first goal that
you have to achieve. So you need some experience with the fro-
zen elephant trunk, for example, to consider using it in a type A
aortic dissection. But we are starting to get more and more
aggressive in using it, especially if there are tears in the aortic
arch. If there are no arch tears when you open the arch, we go
with a proximal arch repair. If we see tears in the distal arch,
we do a frozen elephant trunk. I have to confess, though, that
we don’t know what is perfect sizing, and we are still trying to
figure that out.
Dr Bavaria. I have a couple of questions as well. This is for our
Japanese surgeons, as well as Dr Griepp maybe. This issue was
raised by Dr Coselli. We have a couple of groups, maybe onemajor
group, that uses circulatory arrest alone for all arch cases, a number
of groups that use RCP alone. Are RCP and straight HCA dead at
this point? I noticed in the Japanese literature, Dr Okita, that 10%
or 15% of the surgeons still use RCP. Can you comment on that?
Then maybe we can go down the panel with the arch surgeons. Is it
all ACP now, with everything else dead? Or not?
Dr Okita. I only use deep HCA and RCP on very simple cases
and hemiarches.
Dr Bavaria. This is important. So you use RCP for straightfor-
ward open distal anastomoses, hemiarches, and ACP for all total
arches?
Dr Okita. In selected patients. For complicated cases or a very
sick patient, I always use ACP in hemiarch repair, because we
switched to ACP from RCP. We had a circulatory arrest time of
40 or 50 minutes with RCP with HCA; we had a lot of patients
with transient neurologic deficits. So we changed to ACP.
Dr Bavaria. So that is Dr Kazui’s paradigm, too: if circulatory
arrest time is less than 30minutes for a hemiarch then use RCP; for
everything else, ACP.
Dr Okita. No, shorter than that: 20 minutes.
Dr Ogino. Our approach is different. I use ACP for all cases.
Our technique is very simple: right axillary artery cannulation
and femoral cannulation. This technique we use for all patients,
even with aortic dissection. We call this double cannulation. It is
very simple. It is quite easy; just a clamp on the innominate artery
as ACP is started. So our basic method is ACP.
Dr Bavaria. So, Dr Coselli, do you do ACP even for 20-minute
circulatory arrest times?
Dr Coselli. We quit using RCP years ago, just abandoned it.
Since we moved to axillary and innominate artery sites forThe Journal of Thoracic and Cardcannulation, not to use ACP in some form or fashion, even for
a short period of circulatory arrest, is not very appealing.
Dr Bavaria. Roberto, and this is also for the panel if anybody
wants to join in, regarding reoperations and the whole concept
of left ventricular venting. It seems that many surgeons kind of
blow that off. They don’t look at it as a very important concept,
whereas many of us actually feel it is really critical, even to the
point, as you showed, of doing a small left thoracotomy. Can
you tell us about your approaches to left ventricular venting in
the reoperations? What are your thoughts? Sometimes it is hard
to get to anything.
Dr Di Bartolomeo. When reentry into the sternum is difficult,
and if there is severe aortic valve insufficiency, I think it is very im-
portant to put the vent in the left ventricle. It is a very simple tech-
nique to introduce a small vent in the apex of the left ventricle.
Another important thing about which I think I spoke during the
presentation is the isolation of the innominate artery before open-
ing the sternum. Because in these cases when you arrive at the tem-
perature you want—26C, 25C, 24C—you put a clamp on the
innominate artery and reduce cardiopulmonary bypass flow; gen-
erally, I use 800 mL in the left axillary artery. In these cases,
you have perfusion of the cerebral regions and in the majority of
the cases also the left hemisphere and then can open the sternum.
Dr Bavaria. Dr Griepp? Again, it is very difficult sometimes in
these really bad reoperations to get into venting anatomies.
Dr Griepp. I actually wanted to comment on something else. I
want to say a word about the issue of paraplegia and elephant
trunks and frozen elephant trunks. It started out being a tremendous
conundrum to me that in doing descending thoracic aortic open
surgery, one only extremely rarely saw a spinal cord insult from
a resection limited to the chest. I don’t buy the concept that it is
the elephant trunk occluding segmental vessels that’s causing the
paraplegia.
There are basically three issues that I think need to be kept in
mind if this 5% or 7% or sometimes 3% incidence of paraplegia
in elephant trunks is going to be dealt with.
One concerns perfusion of the left subclavian: the problem of
leaving the left subclavian without perfusion for the long term.
There is lots of experimental evidence and some from clinical se-
ries too, that you need the left subclavian if you are going to take
out a number of segmental vessels. So that’s the first reason one
might get paraplegia with an elephant trunk. The second is the in-
jury to the spinal cord from lower body circulatory arrest at
warmer temperatures. In many cases, there is a sublethal injury de-
livered to the cord. It may be only 30minutes at 30C or something
like that. The cord may recover under optimal circumstances, but
then on top of that you have a patient who has undergone a big,
complex operation and who is probably not going to be hemody-
namically stable to the same extent that your descending thoracic
open case has been. The patient may be intubated for a couple of
days, and nobody is going to be paying attention to keeping the
blood pressure up. Particularly if there is a little bleeding, the blood
pressure is allowed to drift down. So then you take the combination
of a sublethal injury from not perfusing the cord, or particularly the
lower part of the cord, during selective cerebral perfusion and then
on top of that you superimpose some instability in postoperative
hemodynamics. I think those are probably the main considerations
in causing spinal cord injury in these patients. I would hope thatiovascular Surgery c Volume 145, Number 3S S121
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spinal cord injury with elephant trunks.
Dr Miller. I just would like to give an answer to your point
about reoperations. Roberto, I agree 100%. You have the chronic
third- and fourth-time reoperations with a lot of aortic regurgita-
tion. You have to open the sternum under circulatory arrest. You
can make the little thoracotomy you described, but for 5 or 10
years we have just been venting the apex percutaneously with
transesophageal echocardiographic guidance. Remember, those
of you who were at the National Institutes of Health in the old
days; all could do a percutaneous left ventricular stick. TheS122 The Journal of Thoracic and Cardiovascular Surpoints of maximal impulse are really out there, the ventricle is
big, and over a wire one can just put in an 18F EOPA cannula
or something like that, and then later on dissect it out and put
a stitch in it. This has been part of the TEVAR experience, as
I think you have shown us. Someday we are going to be doing
percutaneous transapical TEVARs.
Dr Bavaria. Do you mean transcatheter aortic valve
implantations?
Dr Miller. Transcatheter aortic valve implantations. But you
have done a TEVAR through the apex too. More than one?
Dr Bavaria. More than one.gery c March 2013
